GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » Common Stock

Myrexis (FRA:R9M) Common Stock : €0.26 Mil (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Myrexis Common Stock?

Myrexis's quarterly common stock increased from Dec. 2012 (€0.21 Mil) to Mar. 2013 (€0.27 Mil) but then declined from Mar. 2013 (€0.27 Mil) to Jun. 2013 (€0.26 Mil).

Myrexis's annual common stock increased from Jun. 2011 (€0.18 Mil) to Jun. 2012 (€0.21 Mil) and increased from Jun. 2012 (€0.21 Mil) to Jun. 2013 (€0.26 Mil).


Myrexis Common Stock Historical Data

The historical data trend for Myrexis's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis Common Stock Chart

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Common Stock
Get a 7-Day Free Trial 0.17 0.21 0.18 0.21 0.26

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.21 0.21 0.27 0.26

Myrexis Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Myrexis (FRA:R9M) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis (FRA:R9M) Headlines

No Headlines